JP2004504382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004504382A5 JP2004504382A5 JP2002514101A JP2002514101A JP2004504382A5 JP 2004504382 A5 JP2004504382 A5 JP 2004504382A5 JP 2002514101 A JP2002514101 A JP 2002514101A JP 2002514101 A JP2002514101 A JP 2002514101A JP 2004504382 A5 JP2004504382 A5 JP 2004504382A5
- Authority
- JP
- Japan
- Prior art keywords
- mammal
- medicament
- tumor
- treating
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10035927A DE10035927A1 (de) | 2000-07-21 | 2000-07-21 | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| PCT/EP2001/008263 WO2002008194A1 (de) | 2000-07-21 | 2001-07-18 | Acridin-derivate und deren verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004504382A JP2004504382A (ja) | 2004-02-12 |
| JP2004504382A5 true JP2004504382A5 (enExample) | 2005-02-17 |
Family
ID=7649979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002514101A Withdrawn JP2004504382A (ja) | 2000-07-21 | 2001-07-18 | アクリジン誘導体および医薬としてのその使用 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6706722B2 (enExample) |
| EP (1) | EP1301485B1 (enExample) |
| JP (1) | JP2004504382A (enExample) |
| KR (1) | KR20030022296A (enExample) |
| CN (1) | CN1296359C (enExample) |
| AR (1) | AR033383A1 (enExample) |
| AT (1) | ATE365717T1 (enExample) |
| AU (2) | AU2001289675B2 (enExample) |
| BG (1) | BG107507A (enExample) |
| BR (1) | BR0112591A (enExample) |
| CA (1) | CA2353360A1 (enExample) |
| CY (1) | CY1106890T1 (enExample) |
| CZ (1) | CZ2003427A3 (enExample) |
| DE (2) | DE10035927A1 (enExample) |
| DK (1) | DK1301485T3 (enExample) |
| ES (1) | ES2291349T3 (enExample) |
| HU (1) | HUP0303729A3 (enExample) |
| IL (1) | IL153476A0 (enExample) |
| MX (1) | MXPA02012564A (enExample) |
| NO (1) | NO324939B1 (enExample) |
| NZ (1) | NZ524155A (enExample) |
| PL (1) | PL358808A1 (enExample) |
| PT (1) | PT1301485E (enExample) |
| RU (1) | RU2267488C2 (enExample) |
| SK (1) | SK1932003A3 (enExample) |
| UA (1) | UA75085C2 (enExample) |
| WO (1) | WO2002008194A1 (enExample) |
| ZA (1) | ZA200210411B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10035928A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10037310A1 (de) * | 2000-07-28 | 2002-02-07 | Asta Medica Ag | Neue Indolderivate und deren Verwendung als Arzneimittel |
| MXPA04012959A (es) * | 2002-06-29 | 2005-05-16 | Zentaris Gmbh | Arilcarbonilpiperacinas y heteroarilcarbonilpiperacinas y su uso para tratamiento de enfermedades de tumor benigno y maligno. |
| EP1521748A1 (de) * | 2002-07-17 | 2005-04-13 | Zentaris GmbH | Neue anthracen-derivate und deren verwendung als arzneimittel |
| US7125461B2 (en) * | 2003-05-07 | 2006-10-24 | L & L Products, Inc. | Activatable material for sealing, baffling or reinforcing and method of forming same |
| AR044586A1 (es) * | 2003-06-04 | 2005-09-21 | Aventis Pharma Sa | Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion |
| FR2855825B1 (fr) * | 2003-06-04 | 2008-08-22 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
| US7249415B2 (en) * | 2003-06-26 | 2007-07-31 | Zephyros, Inc. | Method of forming members for sealing or baffling |
| DE10331500A1 (de) * | 2003-07-11 | 2005-02-24 | Zentaris Gmbh | Neue Acridin-Derivate und deren Verwendung als Arzneimittel |
| WO2006080043A2 (en) * | 2005-01-27 | 2006-08-03 | Alma Mater Studiorum- Universita' Di Bologna | Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| US20070299093A1 (en) * | 2005-01-27 | 2007-12-27 | Alma Mater Studiorum-Universitá Di Bologna | Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation |
| EP2125750B1 (en) * | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| JP5470557B2 (ja) * | 2007-07-26 | 2014-04-16 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成 |
| AR069207A1 (es) * | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) * | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| JP5490020B2 (ja) * | 2008-01-24 | 2014-05-14 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター |
| WO2009102428A2 (en) * | 2008-02-11 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| CA2715290A1 (en) * | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| EP2274287B1 (en) * | 2008-03-18 | 2016-03-09 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| EP2291373B1 (en) * | 2008-05-01 | 2013-09-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| US8592410B2 (en) | 2008-05-01 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1 |
| JP5301563B2 (ja) * | 2008-05-01 | 2013-09-25 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター |
| TW201004945A (en) | 2008-05-01 | 2010-02-01 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2010127237A2 (en) * | 2009-04-30 | 2010-11-04 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| JP5379160B2 (ja) | 2008-07-25 | 2013-12-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター |
| CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| US8637505B2 (en) | 2009-02-04 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW201039034A (en) * | 2009-04-27 | 2010-11-01 | Chunghwa Picture Tubes Ltd | Pixel structure and the method of forming the same |
| MA33216B1 (fr) | 2009-04-30 | 2012-04-02 | Boehringer Ingelheim Int | Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1 |
| EP2440537A1 (en) | 2009-06-11 | 2012-04-18 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| EP2448928B1 (en) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| EP2582698B1 (en) | 2010-06-16 | 2016-09-14 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| EP2585444B1 (en) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| WO2012059416A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2538388B1 (fr) | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| EP0318235A3 (en) * | 1987-11-25 | 1991-05-02 | Takeda Chemical Industries, Ltd. | Paf antagonist, 1,4-disubstituted piperazine compounds and production thereof |
| US5030631A (en) * | 1989-11-27 | 1991-07-09 | Schering Corporation | Tricylclic arylsulfonamides |
| RU2126001C1 (ru) * | 1995-01-10 | 1999-02-10 | Самдзин Фармасьютикал Ко., Лтд | Производные пиперазина и фармацевтическая композиция на их основе |
| TR199800371T1 (xx) * | 1996-06-29 | 1998-06-22 | Samjin Pharmaceutical Co.Ltd. | Piperazine t�revleri ve bunlar�n haz�rlanma prosesi. |
| US5861395A (en) | 1996-09-13 | 1999-01-19 | Schering Corporation | Compounds useful for inhibition of farnesyl proteins transferase |
| FR2753706B1 (fr) | 1996-09-20 | 1998-10-30 | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| DE19743435A1 (de) | 1997-10-01 | 1999-04-08 | Merck Patent Gmbh | Benzamidinderivate |
| WO2000012074A2 (en) | 1998-08-28 | 2000-03-09 | Scios Inc. | Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| CA2362495A1 (en) | 1999-03-03 | 2000-09-08 | Theresa M. Williams | Inhibitors of prenyl-protein transferases |
-
2000
- 2000-07-21 DE DE10035927A patent/DE10035927A1/de not_active Withdrawn
-
2001
- 2001-07-18 ES ES01969410T patent/ES2291349T3/es not_active Expired - Lifetime
- 2001-07-18 PT PT01969410T patent/PT1301485E/pt unknown
- 2001-07-18 CZ CZ2003427A patent/CZ2003427A3/cs unknown
- 2001-07-18 DE DE50112669T patent/DE50112669D1/de not_active Expired - Fee Related
- 2001-07-18 NZ NZ524155A patent/NZ524155A/en unknown
- 2001-07-18 WO PCT/EP2001/008263 patent/WO2002008194A1/de not_active Ceased
- 2001-07-18 AU AU2001289675A patent/AU2001289675B2/en not_active Ceased
- 2001-07-18 IL IL15347601A patent/IL153476A0/xx unknown
- 2001-07-18 RU RU2003105283/04A patent/RU2267488C2/ru not_active IP Right Cessation
- 2001-07-18 EP EP01969410A patent/EP1301485B1/de not_active Expired - Lifetime
- 2001-07-18 KR KR10-2003-7000878A patent/KR20030022296A/ko not_active Ceased
- 2001-07-18 PL PL01358808A patent/PL358808A1/xx not_active Application Discontinuation
- 2001-07-18 MX MXPA02012564A patent/MXPA02012564A/es active IP Right Grant
- 2001-07-18 AT AT01969410T patent/ATE365717T1/de not_active IP Right Cessation
- 2001-07-18 DK DK01969410T patent/DK1301485T3/da active
- 2001-07-18 HU HU0303729A patent/HUP0303729A3/hu unknown
- 2001-07-18 CN CNB018131379A patent/CN1296359C/zh not_active Expired - Fee Related
- 2001-07-18 AU AU8967501A patent/AU8967501A/xx active Pending
- 2001-07-18 SK SK193-2003A patent/SK1932003A3/sk not_active Application Discontinuation
- 2001-07-18 BR BR0112591-5A patent/BR0112591A/pt not_active IP Right Cessation
- 2001-07-18 UA UA2003021451A patent/UA75085C2/uk unknown
- 2001-07-18 JP JP2002514101A patent/JP2004504382A/ja not_active Withdrawn
- 2001-07-20 CA CA002353360A patent/CA2353360A1/en not_active Abandoned
- 2001-07-20 US US09/910,142 patent/US6706722B2/en not_active Expired - Fee Related
- 2001-07-20 AR ARP010103480A patent/AR033383A1/es unknown
-
2002
- 2002-12-23 ZA ZA200210411A patent/ZA200210411B/xx unknown
-
2003
- 2003-01-20 NO NO20030301A patent/NO324939B1/no not_active IP Right Cessation
- 2003-01-30 BG BG107507A patent/BG107507A/bg unknown
-
2007
- 2007-09-26 CY CY20071101236T patent/CY1106890T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004504382A5 (enExample) | ||
| JP2004504381A5 (enExample) | ||
| EP1311262A4 (en) | COMBINED TREATMENT AGAINST CANCER | |
| NO20041882L (no) | Fremgangsmater for behandling av okulare neovaskulaere sykdommer. | |
| JP2003503454A5 (enExample) | ||
| NO20034166L (no) | Molekyl¶re konjugater for anvendelse ved behandling av cancer | |
| IL155093A0 (en) | Morpholin-acetamide derivatives for the treatment on inflammatory diseases | |
| EP1608964A4 (en) | CREATING AN EXPRESSION PROFILE OF TUMORS | |
| DE60142473D1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| DE60143393D1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| MXPA03002813A (es) | Compuestos utiles en el tratamiento de enfermedades inflamatorias. | |
| ATE491436T1 (de) | Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen | |
| EE04747B1 (et) | Amiini-plaatina komplekside valmistamismeetod | |
| AR028476A1 (es) | Tratamiento del cancer | |
| ID26300A (id) | Benda penyerap sekali pakai | |
| NO20040516L (no) | Kombinasjonsterapi for behandling av kreft. | |
| NO20033042D0 (no) | Cyklodekstrin-inneholdende farmasöytisk preparat | |
| JP2003526626A5 (enExample) | ||
| NO20015425L (no) | Antitranspirasjonsstift | |
| JP2005509503A5 (enExample) | ||
| EE200200605A (et) | Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks | |
| NO20014228D0 (no) | Radioaktiv cisplatin i behandling av cancer | |
| NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
| RU99127647A (ru) | Средство для лечения сексуальных дисфункций у мужчин | |
| RU2000115217A (ru) | Средство для лечения хронического эндометрита |